Stereotaxis (OTCMKTS:STXS) Stock Rating Lowered by ValuEngine

Stereotaxis (OTCMKTS:STXS) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, ValuEngine reports.

Shares of STXS traded down $0.03 during mid-day trading on Thursday, hitting $2.10. 18,574 shares of the company traded hands, compared to its average volume of 71,331. The business has a 50-day moving average price of $2.67. Stereotaxis has a 1 year low of $0.72 and a 1 year high of $3.00.

Stereotaxis (OTCMKTS:STXS) last released its quarterly earnings data on Thursday, May 9th. The medical equipment provider reported ($0.04) earnings per share for the quarter. Stereotaxis had a negative net margin of 11.71% and a negative return on equity of 329.68%. The company had revenue of $7.01 million for the quarter.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures.

Featured Story: How to trade on quiet period expirations

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.